Cycurion Regains Compliance with the Nasdaq Bid Price Requirement and Consequently Nasdaq Hearing Canceled
Cycurion (NASDAQ: CYCU) announced that Nasdaq has determined the company has regained compliance with the minimum bid price requirement under Listing Rule 5450(a)(1).
Nasdaq confirmed the previously scheduled hearing before the Nasdaq Hearings Panel on November 20, 2025 has been canceled, and Cycurion's securities will continue to be listed and traded on The Nasdaq Stock Market without interruption. The company said this outcome allows management to remain focused on executing strategic priorities and creating long-term shareholder value.
Cycurion (NASDAQ: CYCU) ha annunciato che Nasdaq ha determinato che l'azienda ha ritrovato la conformità al requisito del prezzo minimo di chiusura secondo la Listing Rule 5450(a)(1).
Nasdaq ha confermato che l'udienza precedentemente fissata davanti al Nasdaq Hearings Panel il 20 novembre 2025 è stata annullata, e i titoli di Cycurion continueranno a essere quotati e negoziati sul Nasdaq Stock Market senza interruzioni. L'azienda ha dichiarato che questo esito consente alla direzione di rimanere concentrata sull'esecuzione delle priorità strategiche e sulla creazione di valore per gli azionisti nel lungo termine.
Cycurion (NASDAQ: CYCU) anunció que Nasdaq ha determinado que la empresa ha vuelto a cumplir con el requisito de precio de oferta mínimo bajo la Regla de Listado 5450(a)(1).
Nasdaq confirmó que la audiencia previamente programada ante el Nasdaq Hearings Panel el 20 de noviembre de 2025 ha sido cancelada, y los valores de Cycurion seguirán cotizando y negociándose en The Nasdaq Stock Market sin interrupciones. La compañía dijo que este resultado permite a la dirección centrarse en la ejecución de las prioridades estratégicas y en la creación de valor para los accionistas a largo plazo.
Cycurion (NASDAQ: CYCU)은 Nasdaq이 회사가 상장 규칙 5450(a)(1)에 따른 최저입찰가 요건을 다시 충족하게 되었음을 확인했습니다.
Nasdaq은 2025년 11월 20일에 Nasdaq Hearings Panel 앞에서 예정되었던 청문회가 취소되었으며 Cycurion의 유가증권은 Nasdaq Stock Market에 지장 없이 계속 상장 및 거래될 것이라고 확인했습니다. 회사는 이 결과가 경영진이 전략적 우선순위를 실행하고 장기 주주가치를 창출하는 데 집중할 수 있게 한다고 말했습니다.
Cycurion (NASDAQ: CYCU) a annoncé que Nasdaq a déterminé que la société a retrouvé le respect de l'exigence de prix d'offre minimum en vertu de l'Article de liste 5450(a)(1).
Nasdaq a confirmé que l'audience préalablement programmée devant le Nasdaq Hearings Panel le 20 novembre 2025 a été annulée, et les valeurs de Cycurion continueront d'être listées et négociées sur The Nasdaq Stock Market sans interruption. La société a déclaré que ce résultat permet à la direction de rester concentrée sur l'exécution des priorités stratégiques et la création de valeur pour les actionnaires à long terme.
Cycurion (NASDAQ: CYCU) gab bekannt, dass Nasdaq festgestellt hat, dass das Unternehmen die Mindestkursanforderung gemäß Listing Rule 5450(a)(1) wieder erfüllt.
Nasdaq bestätigte, dass die zuvor angesetzte Anhörung vor dem Nasdaq Hearings Panel am 20. November 2025 abgesagt wurde und die Wertpapiere von Cycurion weiterhin am Nasdaq Stock Market ohne Unterbrechung gelistet und gehandelt werden. Das Unternehmen sagte, dass dieses Ergebnis dem Management ermögliche, sich auf die Umsetzung strategischer Prioritäten zu konzentrieren und langfristigen Aktionärswert zu schaffen.
Cycurion (NASDAQ: CYCU) أعلن أن Nasdaq قد قرر أن الشركة استعادت الامتثال لمتطلب سعر العرض الأدنى بموجب قاعدة الإدراج 5450(a)(1).
أكدت Nasdaq أن جلسة الاستماع التي كانت مقررة سابقاً أمام لجنة جلسات الاستماع Nasdaq في 20 نوفمبر 2025 قد أُلغيت، وأن أدوات Cycurion المالية ستظل مدرجة وتُتَاجر في Nasdaq Stock Market دون انقطاع. قالت الشركة إن هذا القرار يسمح للإدارة بالتركيز على تنفيذ الأولويات الاستراتيجية وخلق قيمة للمساهمين على المدى الطويل.
- Regained Nasdaq bid price compliance under Listing Rule 5450(a)(1)
- Nasdaq hearing scheduled for Nov 20, 2025 canceled
- Listing and trading on Nasdaq will continue without interruption
- Company previously failed to meet Nasdaq minimum bid price requirement, prompting a hearing
MCLEAN, Va., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (“Cycurion” or the “Company”) (NASDAQ: CYCU), a publicly traded leader in AI-powered technology and IT solutions, today announced that the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that Nasdaq has determined that the Company has regained compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5450(a)(1). The Company is now in compliance with Nasdaq Global Market’s listing requirements.
Nasdaq has confirmed that the previously scheduled hearing before the Nasdaq Hearings Panel on November 20, 2025 has been canceled. Cycurion’s securities will continue to be listed and traded on The Nasdaq Stock Market without interruption.
“We are pleased to have regained compliance with the Nasdaq Global Market’s listing requirements and resolved this matter promptly,” said Kevin Kelly, Chairman and Chief Executive Officer of Cycurion. “This outcome reflects the continued support of our investors and allows us to maintain full focus on executing our strategic priorities and creating long-term shareholder value.”
About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future.
For more information, visit www.cycurion.com.
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s common stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.
Cycurion Investor Relations:
(888) 341-6680
investors@cycurion.com
Cycurion Media Relations:
(888) 341-6680
media@cycurion.com
FAQ
What did Cycurion (CYCU) announce on November 11, 2025 regarding Nasdaq compliance?
Was the Nasdaq hearing for Cycurion (CYCU) canceled and when was it scheduled?
Will Cycurion (CYCU) remain listed and tradable on Nasdaq after regaining compliance?
How does regaining Nasdaq compliance affect Cycurion (CYCU) management priorities?
Which Nasdaq rule did Cycurion (CYCU) regain compliance with?
